EBIT at other companies
Other financials
Where this comes from
Calculated from Vir Biotechnology, Inc.’s reported figures.
Plus components not separately reported this period.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s EBIT?
- Vir Biotechnology, Inc. (VIR) reported EBIT of -$132.29M in Q1 2026.
- How has Vir Biotechnology, Inc.'s EBIT changed year-over-year?
- Vir Biotechnology, Inc.'s EBIT increased by 5.2% year-over-year, from -$139.55M to -$132.29M.
- What is the long-term trend for Vir Biotechnology, Inc.'s EBIT?
- Over 3 years (2021 to 2025), Vir Biotechnology, Inc.'s EBIT has grown at a 4.4% compound annual growth rate (CAGR), from $420.75M to -$479.33M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.